Long-term resveratrol administration reduces renal oxidative stress and apoptosis rate in experimental model of type 2 diabetes

Life Science Journal

Volumn 9, Issue 4, 2012, Pages 2997-3001

  Khamneh, Saeed ^a   Ghadiri Soufi, Farhad ^b   Afshar, Fatemeh ^a  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cell death; Diabetes; Hyperglycemia; Oxidative stress; Resveratrol

Indexed keywords

RATTUS; RATTUS NORVEGICUS;

EID: 84877037281     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Balakumar, P., V. A. Chakkarwar and M. Singh, 2009. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. Mol. Cell. Biochem., 320: 149-162.
2. Barber A. J., T. W. Gardner and S. F. Abcouwer, 2011. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 52: 1156-1163.
3. Chang C. C., C. Y. Chang, Y. T. Wu, J. P. Huang and T. H. Yen et al., 2011. Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMPactivated protein kinase. J. Biomed. Sci., 18: 47-56.
4. Chen K. H., C. C. Hung, H. H. Hsu, Y. H. Jing and C. W. Yang et al., 2011. Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic rats. Chem. Biol. Interact., 190: 45-53.
5. Csiszar A., 2011. Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease. Ann. N. Y. Acad. Sci., 1215: 117-122.
6. Cottart C. H., V. Nivet-Antoine, C. Laguillier-Morizot and J. L. Beaudeux, 2010. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food. Res., 54: 7-16.
7. Davi G., A. Falco and C. Patrono, 2005. Lipid peroxidation in diabetes mellitus. Antioxid. Redox. Signal., 7: 256-268.
8. Howlett J. and M. Ashwell, 2008. Glycemic response and health: summary of a workshop. Am. J. Clin. Nutr., 87: 212S-216S.
9. Kern T. S., 2007. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes. Res., 2007: 95103.
10. Kitada M., S. Kume, N. Imaizumi and D Koya, 2011. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes, 60: 634-643.
11. Lee S. M., H. Yang, D. M. Tartar, B. Gao and X. Luo et al., 2011. Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes. Diabetologia, 54: 1136-1146.
12. Luis-Rodríguez D., Martínez-Castelao A., Górriz J. L., De-Álvaro F., Navarro-González J. F. 2012 Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes 15: 7-18.
13. Maritim A. C., R. A. Sanders and J. B. Watkins III, 2003. Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol., 17: 24-38.
14. Masiello P., C. Broca, R. Gross, M. Roye and M. Manteghetti et al., 1998. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes, 47: 224-229.
15. Morrow J. D., B. Frei, A. W. Longmire, J. M. Gaziano and S. M. Lynch et al., 1995. Increase in circulating products of lipid peroxidation (F2-isoprostane) in smokers. N. Engl. J. Med., 332: 1198-1203.
16. Ndisang J. F., N. Lane, N. Syed and A. Jadhav, 2010. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology, 151: 549-560.
17. Palsamy P. and S. Subramanian, 2008. Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats. Biomed. Pharmacother., 62: 598-605.
18. Palsamy P. and S. Subramanian, 2010. Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic β-cell dysfunction in streptozotocinnicotinamide-induced diabetic rats. J. Cell. Physiol., 224: 423-432.
19. Palsamy P. and S. Subramanian, 2011. Resveratrol protects diabetic kidney by attenuating hyperglycemiamediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim. Biophys. Acta., 1812: 719-731.
20. Pitocco D., F. Zaccardi, E. Di Stasio, F. Romitelli and S. A. Santini et al., 2010. Oxidative Stress, Nitric Oxide, and Diabetes. Rev. Diabet. Stud., 7: 15-25.
21. Rains J. L. and S. K., 2011. Jain Oxidative stress, insulin signaling, and diabetes. Free. Radic. Biol. Med., 50: 567-575.
22. Roghani M. and T. Baluchnejadmojarad, 2010. Mechanisms underlying vascular effect of chronic resveratrol in streptozotocin-diabetic rats. Phytother. Res., 24, S148-S154.
23. Salim S., M. Asghar, G. Chugh, M. Taneja and Xia Z et al., 2010. Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance. Brain. Res., 1359: 178-185.
24. Schmatz R., M. R. Schetinger, R. M. Spanevello, C. M. Mazzanti and N. Stefanello et al., 2009. Effect of resveratrol on nuleotide degradig enzymes in streptozotocin-induced diabetic rats. Life. Sci., 84: 345-350.
25. Szkudelska K. and T. Szkudelski, 2010. Resveratrol, obesity and diabetes. Euro. J. Pharmachol. 635: 1-8.
26. Szkudelski T and K., 2011. Szkudelska Anti-diabetic effects of resveratrol. Ann. N. Y. Acad. Sci. 1215: 34-39.